Atlas Trials

Astellas Pharma Inc

523 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Astellas Pharma Inc

RecordFirmDate
A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke (NCT07318714)Astellas Pharma Inc2026-04-03
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors (NCT07094204)Astellas Pharma Inc2025-07-25
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration (NCT06970665)Astellas Pharma Inc2025-07-08
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors (NCT06364696)Astellas Pharma Inc2024-04-16
A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause (NCT06206421)Astellas Pharma Inc2024-02-22
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Menopause (NCT06206408)Astellas Pharma Inc2024-02-16
A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery (NCT05457842)Astellas Pharma Inc2022-08-10
A Study of ASP3082 in Adults With Advanced Solid Tumors (NCT05382559)Astellas Pharma Inc2022-06-08
A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause (NCT05034042)Astellas Pharma Inc2021-11-17
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants (NCT04878471)Astellas Pharma Inc2021-06-02
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD) (NCT04184882)Astellas Pharma Inc2021-02-24
A Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery (NCT04238481)Astellas Pharma Inc2020-10-06
Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia (NCT04408820)Astellas Pharma Inc2020-06-01
A Study to Assess Effect of Exercise Program Provided by Smartphone Application on the Body Composition (NCT04194697)Astellas Pharma Inc2019-12-25
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery (NCT03941483)Astellas Pharma Inc2019-11-01
Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors (NCT04094506)Astellas Pharma Inc2019-10-30
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis (NCT03971253)Astellas Pharma Inc2019-09-02
Study of ASP8374, an Immune Checkpoint Inhibitor, in Japanese Patients With Advanced Solid Tumors (NCT03945253)Astellas Pharma Inc2019-08-05
Development of Visual Function Evaluation Method (2) (NCT03626207)Astellas Pharma Inc2018-10-04
A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma (NCT03528629)Astellas Pharma Inc2018-06-08
A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder (NCT03403790)Astellas Pharma Inc2018-01-15
ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects (NCT03361540)Astellas Pharma Inc2017-11-14
Development of Visual Function Evaluation Method (NCT03281005)Astellas Pharma Inc2017-11-01
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation (NCT03182244)Astellas Pharma Inc2017-10-25
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer (NCT03219333)Astellas Pharma Inc2017-10-08
Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases) (NCT03471728)Astellas Pharma Inc2017-10-02
A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate (NCT03257852)Astellas Pharma Inc2017-09-29
Next →

Track Astellas Pharma Inc automatically

Every clearance here is in the API, with alerts when new ones post.